ES2722973T3 - Obtención de imágenes en enfermedades neurológicas - Google Patents

Obtención de imágenes en enfermedades neurológicas Download PDF

Info

Publication number
ES2722973T3
ES2722973T3 ES14742544T ES14742544T ES2722973T3 ES 2722973 T3 ES2722973 T3 ES 2722973T3 ES 14742544 T ES14742544 T ES 14742544T ES 14742544 T ES14742544 T ES 14742544T ES 2722973 T3 ES2722973 T3 ES 2722973T3
Authority
ES
Spain
Prior art keywords
iii
relationship
subject
stage
neurological diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14742544T
Other languages
English (en)
Spanish (es)
Inventor
Mark Joseph Rosser
Jan Wolber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Application granted granted Critical
Publication of ES2722973T3 publication Critical patent/ES2722973T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/501—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
ES14742544T 2013-07-25 2014-07-25 Obtención de imágenes en enfermedades neurológicas Active ES2722973T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1313291.5A GB201313291D0 (en) 2013-07-25 2013-07-25 Imaging neurological disease
PCT/EP2014/066042 WO2015011267A1 (en) 2013-07-25 2014-07-25 Imaging neurological disease

Publications (1)

Publication Number Publication Date
ES2722973T3 true ES2722973T3 (es) 2019-08-20

Family

ID=49166921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14742544T Active ES2722973T3 (es) 2013-07-25 2014-07-25 Obtención de imágenes en enfermedades neurológicas

Country Status (16)

Country Link
US (1) US11051777B2 (OSRAM)
EP (1) EP3024501B1 (OSRAM)
JP (1) JP6590801B2 (OSRAM)
KR (1) KR102340504B1 (OSRAM)
CN (1) CN105392500B (OSRAM)
AU (2) AU2014294983B2 (OSRAM)
BR (1) BR112016001316B1 (OSRAM)
CA (1) CA2916125A1 (OSRAM)
DK (1) DK3024501T3 (OSRAM)
ES (1) ES2722973T3 (OSRAM)
GB (1) GB201313291D0 (OSRAM)
IL (1) IL243383B (OSRAM)
MX (1) MX2016001012A (OSRAM)
RU (1) RU2015155792A (OSRAM)
SG (1) SG11201600571RA (OSRAM)
WO (1) WO2015011267A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104720840A (zh) * 2015-02-11 2015-06-24 清华大学深圳研究生院 基于多巴胺转运体显像特异性摄取比的半自动量化方法
TWI587841B (zh) * 2015-03-06 2017-06-21 國立陽明大學 定量分析核子醫學腦部影像的系統及方法
KR20170131829A (ko) * 2015-03-24 2017-11-30 니혼 메디피직스 가부시키가이샤 화상 처리 장치, 화상 처리 방법, 및 프로그램
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
JP6549521B2 (ja) * 2016-05-25 2019-07-24 富士フイルム富山化学株式会社 疾患鑑別支援装置及びコンピュータプログラム
TWI607739B (zh) * 2016-05-27 2017-12-11 許百靈 Spect多巴胺顯像定量分析技術與在腦多巴胺評估的用途
GB201621698D0 (en) * 2016-12-20 2017-02-01 Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center Differential Diagnosis
JP6995642B2 (ja) * 2018-01-19 2022-01-14 日本メジフィジックス株式会社 画像処理装置、画像処理方法およびプログラム
TWI686178B (zh) 2019-10-09 2020-03-01 中原大學 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統
WO2021102323A1 (en) * 2019-11-21 2021-05-27 Likeminds, Inc. Pharmaceutical packaging units and methods for concomitant administration of radiotracers
PE20240822A1 (es) 2021-03-22 2024-04-18 Neurocrine Biosciences Inc Inhibidores de vmat2 y metodos de uso
JP7834281B2 (ja) * 2022-02-18 2026-03-24 社会福祉法人兵庫県社会福祉事業団 画像処理プログラム、画像処理方法、および画像処理装置
CN119599879B (zh) * 2024-11-06 2025-10-24 复旦大学附属华山医院 一种基于深度学习的pet图像跨膜态合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540512A (ja) * 2007-09-26 2010-12-24 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 異なるタイプの認知症を特異的に診断する方法
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level
CA2703563A1 (en) * 2007-10-31 2009-05-07 Alseres Pharmaceuticals, Inc. Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level

Also Published As

Publication number Publication date
EP3024501A1 (en) 2016-06-01
AU2019253837B2 (en) 2021-11-25
CN105392500A (zh) 2016-03-09
EP3024501B1 (en) 2019-03-27
SG11201600571RA (en) 2016-02-26
CN105392500B (zh) 2023-08-18
RU2015155792A (ru) 2017-08-30
US20160183897A1 (en) 2016-06-30
JP2016531903A (ja) 2016-10-13
JP6590801B2 (ja) 2019-10-16
US11051777B2 (en) 2021-07-06
WO2015011267A1 (en) 2015-01-29
KR20160037168A (ko) 2016-04-05
DK3024501T3 (da) 2019-05-06
AU2019253837A1 (en) 2019-11-14
AU2014294983B2 (en) 2019-10-24
MX2016001012A (es) 2016-05-09
BR112016001316B1 (pt) 2021-04-06
AU2014294983A1 (en) 2016-01-21
RU2015155792A3 (OSRAM) 2018-05-23
HK1222118A1 (zh) 2017-06-23
CA2916125A1 (en) 2015-01-29
IL243383B (en) 2018-07-31
KR102340504B1 (ko) 2021-12-20
GB201313291D0 (en) 2013-09-11

Similar Documents

Publication Publication Date Title
MX2019003148A (es) Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados.
BR112015030179A2 (pt) sistema e método de apoio para cuidados com a saúde para determinar o tratamento de um paciente; e programa de computador
MX358517B (es) Métodos para determinar eficacia de fármacos usando proteínas asociadas a cereblon.
UY35232A (es) Derivados de Exendina-4
MX2015012585A (es) Dilatación regulada por flujo para determinar la edad vascular.
EP3825419A3 (en) Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine
BR112015016023A2 (pt) método e aparelho de recomendação de modo de cenário para dispositivo inteligente
UY35548A (es) Péptidos terapéuticos para el tratamiento de trastornos metabólicos.
CO2017000346A2 (es) Anticuerpos de unión a protofibrillas aβ
Pantic Social networking and depression: an emerging issue in behavioral physiology and psychiatric research.
BR112014027594A2 (pt) dispositivo para apoiar uma mudança de comportamento de uma pessoa, método para apoiar uma mudança de comportamento de uma pessoa utilizando um dispositivo e programa de computador
BR112012028452A2 (pt) dispositivos e métodos para avaliar mudanças na saúde da córnea
BR112016006556A2 (pt) arranjos detectáveis, sistemas para diagnóstico, e métodos para produzir e usar os mesmos
BR112014029346A2 (pt) sistema e método implementado por computador para a montagem de um plano de tratamento médico
EP3019629A4 (en) Genetic and image biomarkers associated with decline in cognitive measures and brain glucose metabolism in populations with alzheimer's disease or those susceptible to developing alzheimer's disease
CR20140473A (es) Compuestos de pirazol como inhibidores de sglt1
EA201690537A1 (ru) Способы и средства для введения контрастной среды
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
AR092423A1 (es) Metodo de diagnostico y tratamiento del cancer dirigido a las moleculas expresadas en celulas madre cancerosas
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
BR112015027249A2 (pt) método de diagnóstico de câncer
BR112017027304A2 (pt) método para o diagnóstico de doença de farber
MX371426B (es) Metodo para la prediccion de la aparicion de sintomas extrapiramidales (sep) inducidos por un tratamiento con antipsicoticos.
BR112015017432A2 (pt) métodos para o tratamento de indicações cardiovasculares